Cost-effective management of chronic stable angina

Clinical Cardiology

Volumn 19, Issue 6, 1996, Pages 497-501

  O'Rourke, Robert A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

anti ischemic medical therapy; chronic stable angina; coronary angioplasty; coronary artery bypass graft surgery; cost effective treatment; risk stratification

Indexed keywords

ANTIANGINA PECTORIS AGENT;

ANGINA PECTORIS; CHRONIC DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; HUMAN; LEFT CORONARY ARTERY; PROGNOSIS; REVIEW; TREATMENT PLANNING;

EID: 0029814760     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190611     Document Type: Review

References (22)

1. Kupersmith J, Holmes-Rovner M, Hogan A, Rovner D, Gardiner J: Cost-effectiveness analysis in heart disease. Part II: Preventive therapies. Prog Cardiovasc Dis 1995;37(4):243-271
2. Kent KM, Rosing DR, Ewels CJ, Lipson L, Bonow R, Epstein SE: Prognosis of asymptomatic or mildly symptomatic patients with coronary artery disease. Am J Cardiol 1982;49:1823-1831
3. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group: Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984;311:1333-1339
4. Varnauskas E, and the European Coronary Surgery Study Group: Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988;319:332-337
5. Alderman EL, Bourassa MG, Cohen LS, Davis KB, Kaiser GG, Killip T, Mock MB, Pettinger M, Robertson TL for the CASS Investigators: Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 1990;82:1629-1646
6. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Morris R, Morris C, Mathur V, Varnauskas E, Chalmers TC: Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563-570
7. Moliterno DJ, Elliott JM, Topol EJ: Randomized trials of myocardial revascularization. Curr Probl Cardiol 1995;20(3):121-192
8. Mark DB, Nelson CL, Califf RM, Harrell FE, Lee KL, Jones RH, Fortin DF, Stack RS, Glower DD, Smith LR, DeLong ER, Smith PK, Reves JG, Jollis JG, Tcheng JE, Muhlbaier LH, Lowe JE, Phillips HR, Pryor DB: Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 1994;89:2015-2025
9. Weinstein MC, Stason WB: Cost-effectiveness of coronary artery bypass surgery. Circulation 1982;66:III-56-III-66
10. Parisi AF, Folland ED, Hartigan P on behalf of the Veterans Affairs ACME Investigators: A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16
11. Strauss WE, Fortin T, Hartigan P, Folland ED, Parisi AF, and the Veterans Affairs ACME Investigators: A comparison of quality-of-life scores in patients with angina pectoris after angioplasty compared with medical therapy: Outcomes of a randomized clinical trial. Circulation 1995;90:1710-1719
12. Schlant RC: Coronary angioplasty in patients with stable angina pectoris and one-vessel disease (editorial). Circulation 1995;92: 1676-1677
13. Goy J-J, Eeckhout E, Burnand B, Vogt P, Stauffer J-C, Hurni M, Stumpe F, Ruchat P, Sadeghi H, Kappenberger L: Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994;343: 1449-1453
14. Editorial: BARI, CABRI, EAST, GABI, and RITA; coronary angioplasty on trial. Lancet 1990;335:1315-1316
15. Rodriguez A, Boullion F, Perez-Baliño N, Paviotti C, Liprandi MIS, Palacios IF on behalf of the ERACI Group: Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI): In-hospital results and 2 year followup. J Am Coll Cardiol 1993;22:1060-1067
16. RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: The Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-580
17. Hamm CW, Reimers J, Ischinger T, Rupprecht H-J, Berger J, Bleifeld W, for the German Angioplasty Bypass Surgery Investigation: A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994;331:1037-1043
18. King SB, Lembo NJ, Weintraub WS, Kosinski AJ, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao Q-Q for the Emory Angioplasty versus Surgery Trial (EAST): A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-1050
19. Hampton J, for the RITA Trial Participants: Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341: 573-580
20. Weintraub WS, Mauldin PD, Becker E, King SB: The impact of additional procedures on the cost at three years of coronary angioplasty and coronary surgery in the EAST trial. Circulation 1994;90: 2831-2840
21. Goldman L, Gordon DJ, Rifkind DM, Hulley SB, Detsky AS, Goodman DS, Kinosian B, Weinstein MC: Cost and health implications of cholesterol lowering. Circulation 1992;85:1960-1968
22. Wong JB, Sonnenberg FA, Salem DN, Pauker SG: Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Am Intern Med 1990;113:852-871